Climb Bio, Inc. (CLYM)
↓ Download CSVKey ratios (FY2025)
-37.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$67.88M | -$82.02M | -$40.27M | -$45.13M | -$35.67M | -$20.93M | — |
| Net Income | -$59.85M | -$73.90M | -$35.12M | -$45.24M | -$47.48M | -$20.67M | — |
| EPS (Diluted) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | — | — |
| Total Assets | $167.74M | $217.19M | $110.47M | $134.99M | $173.24M | $24.63M | — |
| Total Liabilities | $7.27M | $5.31M | $2.87M | $6.28M | $6.04M | $3.06M | — |
| Shareholders' Equity | $160.47M | $211.88M | $107.60M | $128.72M | $167.20M | -$24.98M | -$5.56M |
| Cash & Equivalents | $35.69M | $87.23M | $93.11M | $43.59M | $46.92M | $20.49M | — |
| Operating Cash Flow | -$54.36M | -$15.56M | -$20.60M | -$37.37M | -$36.07M | -$14.10M | — |
| Capital Expenditures | $186.0K | $0 | — | — | — | — | — |
| Shares Outstanding | 47.77M | 67.26M | 27.70M | 26.57M | 26.57M | 3.42M | — |